Vijaykumar Bhadabhai Sutariya

This inventor holds 12 USPTO granted patents and 4 published patent applications. Top assignee: University of South Florida. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijaykumar Bhadabhai Sutariya. Retrieved from https://idiyas.com/inventor/vijaykumar-bhadabhai-sutariya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 75.0

Average Co-Inventor Count = 2.9

ph-index = 1

Company Filing History:

12 out of 1,993

University of South Florida

patents

Years Active: 2019-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12409138 - Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration (2025-09-09),

2. 11998562 - Ophthalmological formulations for the prevention of a coronavirus infection (2024-06-04),

3. 11730703 - Nanoparticles for treatment of posterior segment ocular diseases and conditions (2023-08-22),

4. 11471412 - Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration (2022-10-18),

5. 11207274 - Nanoparticles for treatment of posterior segment ocular diseases and conditions (2021-12-28),

6. 11173152 - Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain barrier (2021-11-16),

7. 10973776 - Loteprednol etabonate nanoparticles in thermoreversible gels for enhanced therapeutics (2021-04-13),

8. 10772843 - Nanoparticles for treatment of posterior segment ocular diseases and conditions (2020-09-15),

9. 10765755 - Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies (2020-09-08),

10. 10758520 - Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain barrier (2020-09-01),

11. 10729663 - Nanoparticles in thermoreversible gels for enhanced therapeutics (2020-08-04),

12. 10172867 - Afobazole nanoparticles formulation for enhanced therapeutics (2019-01-08),

Title: Vijaykumar Bhadabhai Sutariya: Innovator in Ophthalmological Drug Compositions

Introduction

Vijaykumar Bhadabhai Sutariya is a prominent inventor based in Tampa, FL (US). He has made significant contributions to the field of ophthalmology, particularly in the development of drug compositions aimed at treating various eye conditions. With a total of 12 patents to his name, Sutariya's work is paving the way for innovative treatments in the medical field.

Latest Patents

Sutariya's latest patents include groundbreaking formulations such as nanoparticles and nanogel drug compositions for the treatment of age-related macular degeneration. These formulations are designed to effectively deliver therapeutic agents to the eye, addressing a condition that affects millions of individuals worldwide. Another notable patent involves ophthalmological compositions for the prevention of coronavirus infections. This innovative composition combines remdesivir with an ophthalmologically suitable carrier, showcasing Sutariya's commitment to addressing urgent health challenges.

Career Highlights

Sutariya is affiliated with the University of South Florida, where he conducts research and develops new medical technologies. His work not only contributes to academic knowledge but also has practical implications for patient care. His dedication to innovation in ophthalmology has earned him recognition in the scientific community.

Collaborations

Sutariya collaborates with esteemed colleagues such as Yashwant V Pathak and Srinivas M Tipparaju. These partnerships enhance the research and development process, allowing for a multidisciplinary approach to tackling complex medical issues.

Conclusion

Vijaykumar Bhadabhai Sutariya is a key figure in the field of ophthalmological innovations. His contributions through patents and collaborations are making a significant impact on the treatment of eye diseases and the prevention of infections. His work exemplifies the importance of innovation in improving healthcare outcomes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents pending: